文献速递主动脉疾病

复杂型B型主动脉夹层腔内干预结局的种族差异

Ethnic disparities in outcomes of patients with complicated type B aortic dissection.
PubMed 文献 · J Vasc Surg · 2018-02-02

单中心回顾性研究纳入2012至2016年126例复杂型TBAD腔内干预患者,比较非裔美国人与白人结局。非裔更年轻且5年生存率更高,但再干预率显著更高,可能与血压控制不佳有关,尽管其服用更多降压药。

要点

  • 非裔复杂型TBAD患者比白人年轻约11岁,5年生存率更高。
  • 非裔患者再干预率显著更高,与血压控制不佳相关。
  • 两组的血压控制均不理想,非裔术后30天未控制高血压比例更高。

核心结论

  • 非裔复杂型TBAD患者较白人发病年龄更轻,至少5年内生存率更高。
  • 非裔患者再干预率更高,可能与血压控制不佳有关,尽管其服用更多降压药物。
  • 所有组别均难以实现最佳药物治疗,非裔患者尤其需要更积极的医疗管理。

研究设计与样本

  • 单中心回顾性队列研究,2012至2016年共126例复杂型TBAD接受腔内干预的患者。
  • 非裔美国人53例,白人70例,亚裔3例;主要比较非裔与白人。
  • 主要结局为生存率和再干预需求。

主要发现

  • 非裔与白人30天、1年、3年、5年生存率分别为94% vs 89%、91% vs 83%、89% vs 79%、89% vs 76%(P = .05)。
  • 非裔患者年龄52.5 ± 11岁,白人63.7 ± 14.7岁(P < .0001)。
  • 非裔患者再干预次数显著更多(P = .007)。
  • 非裔患者慢性肾病(P = .01)、吸烟(P = .03)、可卡因使用(P = .02)比例更高,医疗补助保险比例更高(P = .02)。
  • 术前、术后、术后30天未控制高血压(收缩压>140 mm Hg)比例分别为32%、32%、39%;术后30天非裔49% vs 白人31%(OR 2.1,P = .09)。

临床怎么用

  • 对复杂型TBAD患者应强化血压管理,尤其关注非裔患者。
  • 非裔患者再干预风险较高,需加强术后随访和药物调整。
  • 最佳药物治疗在所有种族中均难以实现,需更积极的干预策略。

局限性

  • 单中心回顾性研究,样本量有限(126例),亚裔仅3例未纳入比较。
  • 种族分组为自我认定,可能存在混杂因素。
  • 术后30天血压控制差异的P值为.09,未达统计学显著性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The objective of this study was to evaluate the difference in outcomes after endovascular intervention in patients with complicated type B aortic dissection (TBAD) based on ethnicity and blood pressure control. METHODS: Between 2012 and 2016, there were 126 patients who underwent endovascular procedures for complicated TBAD at a single-institution quaternary referral center. Patients self-identified as African American (n = 53), white (n = 70), and Asian (n = 3). African American and white patients were compared on a number of variables, including age, ethnicity, insurance type, blood pressure, comorbidities, number of previous interventions, and number of antihypertension medications they were taking before intervention. Primary outcomes were survival and need for reintervention. RESULTS: Kaplan-Meier estimates for survival for African Americans vs whites were 94% vs 89%, 91% vs 83%, 89% vs 79%, and 89% vs 76% at 30 days, 1 year, 3 years, and 5 years, respectively (P = .05). African Americans were younger overall (52.5 ± 11 years) vs whites (63.7 ± 14.7 years; P < .0001). African Americans required a significantly greater number of reinterventions (P = .007). They also had higher rates of chronic kidney disease (P = .01), smoking (P = .03), and cocaine use (P = .02) and were more likely to be on Medicaid (P = .02). Hypertension was poorly controlled in both groups, with the percentage of patients with uncontrolled hypertension (systolic >140 mm Hg) preoperatively, postoperatively, and 30 days after intervention at 32%, 32%, and 39%. There was no significant difference between the cohorts in uncontrolled hypertension preoperatively (P = .39) or postoperatively (P = .63). However, more African Americans had uncontrolled hypertension at 30 days (African Americans, 49%; whites, 31%; odds ratio, 2.1; P = .09). African Americans were taking a greater number of antihypertension medications at presentation than whites (P = .01) and specifically had higher use rates of beta blockers (P = .02), diuretics (P = .02), and angiotensin-converting enzyme inhibitors (P = .04). CONCLUSIONS: African Americans with TBAD present at a younger age than their white counterparts do and have a survival advantage up to at least 5 years. However, African Americans have a higher rate of reintervention that is probably associated with poor blood pressure control despite taking more antihypertension medications both before and after the repair. It appears that optimal medical therapy is difficult to achieve in all groups. More aggressive medical management is needed, particularly more so in African Americans, which may in turn decrease the number of interventions and potentially improve long-term survival.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Yammine H, Ballast JK, Anderson WE, et al. Ethnic disparities in outcomes of patients with complicated type B aortic dissection. J Vasc Surg. 2018. PMID: 29398310. doi:10.1016/j.jvs.2017.10.083

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。